Peptide Merchant Account for Research-Only Businesses
Reliable credit card processing for research-only peptide businesses
- No LegitScript Required
- Stable Long-Term Processing
- Designed for research peptide suppliers
- Built for growing monthly volumes
IMPORTANT: The CERF provides payment processing services for research-only peptide businesses operating in compliance with applicable law. All merchants are required to maintain clear research-only disclaimers on their website, comply with applicable labelling standards, and ensure their business model is structured for research supply only. The CERF does not support businesses selling peptides for human consumption or making therapeutic claims
Why Peptide Businesses Get Shut Down
Mainstream processors flag research peptide businesses as high risk. The pattern is consistent across the industry.
A processor approves the account. Volume grows. Scrutiny increases. Stripe does not permit peptide processing at all. PayPal terminates accounts at first review. Square boards merchants quickly but closes them without warning the moment a chargeback ratio ticks upward or a product SKU triggers a policy flag.
For peptide suppliers, this creates a cycle of constant disruption. Instead of focusing on the business, merchants spend six to twelve months rebuilding payment infrastructure every time an account closes. The cost is not just lost revenue during the gap. It is the customers who do not come back, the ad spend that kept running, and the operational complexity of starting over.
The way to avoid a peptide merchant account shutdown is not to find a more lenient mainstream processor. It is to work with an acquirer that specifically underwrites this vertical from the start.
What You Get With CERF
- Embedded checkout, no redirects
- T+1 / fast payout options available
- Shopify, WooCommerce & custom sites
- Crypto, ACH & wire payout options
- Reserve optimization for qualified merchants
- Multi-bank setup for better payment stability
Why CERF for Peptide Processing
Research peptide merchants need more than basic payment processing. They need a processor who understands the vertical before the account is opened, not one who discovers the risks six months later.
CERF works with acquiring partners that have developed specific frameworks for research-only businesses. This means stable credit card processing, optimised payout structures, and payment infrastructure built to scale with growing peptide brands.
Our high risk merchant accounts use dedicated merchant IDs and multi-bank redundancy. A single processor policy change cannot take your entire revenue offline. We have supported peptide merchants since 2022 and have never terminated a compliant research-only account.
How CERF Underwrites Peptide Merchant Accounts
Most processors that accept peptide businesses do so through automated onboarding. The same system that approved the account in twenty minutes is the one that flags it six months later when transaction patterns shift.
Our underwriting for peptide merchant accounts is manual. We review your business before approval, not after a problem surfaces. That review covers your website compliance, research-only disclaimers, chargeback history, product catalogue, and marketing practices. We also work with research chemical merchant accounts and similar high-scrutiny categories using the same framework.
What we review during onboarding:
- Website compliance and research-only positioning
- Chargeback ratio and dispute history
- Product categories and labelling standards
- Processing volume and growth trajectory
- Prior processor relationships and any terminations
Rolling reserves for peptide merchant accounts are typically 5 to 10 percent of monthly volume in the first six months. Terms are agreed upfront and documented before activation. There are no surprise reserve changes mid-account.
Previous termination by Stripe or PayPal does not disqualify you. We assess the circumstances. Most compliant research-only businesses terminated by mainstream processors are approvable through specialist acquiring.
How the Application Works
Submit your application
Fill out the contact form with your business details, product category, and estimated monthly volume. A peptide payment specialist responds within 24 hours.
Compliance and underwriting review
We review your website, disclaimers, chargeback history, and processing setup. For most research peptide merchants, this takes up to 5 business days.
Account activation
Once approved, your peptide merchant account connects to your checkout. We support Shopify, WooCommerce, and custom integrations for peptide ecommerce businesses. Processing typically starts within 48 hours of final approval
Frequently Asked Questions About Peptide Merchant Accounts
No. For research-only peptide businesses, LegitScript certification is not required. The CERF works with banking partners that approve compliant research peptide merchants without this requirement. You need compliant labeling and clear research-only disclaimers on your website.
Unlike Stripe or PayPal, The CERF uses dedicated high-risk banking partners that specifically support peptide businesses. Our multi-bank approach prevents shutdowns and fund freezes. We have never terminated a compliant peptide merchant account.
Yes. We offer settlement in fiat and cryptocurrency including USDT, BTC and ETH — giving peptide merchants maximum flexibility in how they receive their funds. Crypto settlement is especially popular with international peptide suppliers.
Most research peptide merchants receive approval within 24-48 hours. Apply today and speak with a dedicated account manager who specializes in peptide payment processing.
Previous termination does not disqualify you. The CERF works with banking partners that approve peptide businesses regardless of previous shutdowns, as long as your business is compliant and research-only.
No. Stripe explicitly prohibits peptide and research chemical merchants under its restricted businesses policy. Peptide accounts on Stripe are typically approved initially and then terminated within weeks or months as the account is reviewed by the risk team. This is not a manual decision — it is an automated flag triggered by the merchant category, transaction patterns, or a product name match against Stripe’s restricted list.
PayPal and Square apply similar restrictions. The CERF is a direct alternative to Stripe for research peptide businesses, providing a stable merchant account with a dedicated acquiring bank relationship rather than a payment facilitator account that can be closed without warning. Unlike Stripe, our peptide merchant accounts are not subject to sudden automated reviews.
The approval process for a peptide merchant account depends on your business structure, compliance setup, and processing history. You need a website with clear research-only disclaimers, compliant product labelling, and no therapeutic claims. A documented chargeback history helps, but a clean slate is also acceptable for newer businesses. Previous termination by Stripe or PayPal does not automatically prevent approval. The most common reason peptide merchants are declined is non-compliant website copy, not their product category. If your site clearly positions products for research use only and avoids health claims, approval through a specialist processor like CERF is typically straightforward.
The Growing Demand for Peptide Payment Processing
The global peptide therapeutics market was valued at $52.6 billion in 2025 and continues to grow as both pharmaceutical development and consumer interest in peptide-based compounds accelerates. The driver most visible to payment processors is the GLP-1 category: semaglutide now generates over 1.5 million monthly searches in the United States alone, compared to approximately 74,000 for BPC-157, one of the most widely searched research peptides. That gap is closing. Search interest in broader peptide terms has surged – ‘how to get peptides’ grew over 1,000% in recent trend data, ‘are peptides safe’ grew 652%.
For payment processors, this growth creates a specific challenge. The same consumer awareness that drives demand also increases the scrutiny applied to peptide businesses by card networks and acquiring banks. Merchants who grew steadily through 2022 and 2023 increasingly found their accounts reviewed, restricted or terminated as processor risk models were updated to reflect the higher-profile nature of the category. The CERF has been building peptide merchant accounts since 2022 and has adapted its underwriting alongside these changes, working with acquiring partners who have developed specific frameworks for research-only peptide merchants rather than treating them as generic nutraceutical businesses.
In February 2026, fourteen of nineteen peptides previously under FDA compounding restrictions were reclassified back to Category 1 status, reinstating their availability through licensed compounding pharmacies. This current regulatory landscape for peptide compounding reflects the ongoing evolution of the space — and underscores why payment infrastructure built on static risk models consistently fails peptide merchants over time. Stable processing in this vertical requires a processor who tracks these changes, not one who discovers them after terminating an account.
Apply for Your Peptide Merchant Account Today
Research-only peptide processing, flexible settlement options and dedicated high-risk support
The Cerf
CERF — SAS
SIREN : 913 596 649
RCS Paris
219 Boulevard Pereire, 75017 Paris
© thecerf.com
CERF SAS is a company registered in France under SIREN number 913 596 649, RCS Paris. Registered office: 219 Boulevard Pereire, 75017 Paris, France. CERF SAS operates as a payment solutions provider and works with a network of licensed Merchant Acquirers across the US, Canada, UK, Europe and LATAM. These acquirers are responsible for the processing of card transactions on behalf of merchants. Merchants will be required to enter into and maintain a separate processing agreement with an acquiring bank nominated by CERF. Under the terms of that agreement, transaction fees, reserve requirements and other charges will apply as agreed during onboarding. Rates referenced on this website are indicative and representative of typical fees charged by our acquiring partners; final pricing is confirmed at the time of merchant approval